Skip to main content

Table 3 Two-tailed T-test before and after OM infusion on LV function after 2 months of AR in a rat model (n = 7)

From: Effects of the cardiac myosin activator Omecamtiv-mecarbil on severe chronic aortic regurgitation in Wistar rats

 

Before infusion

After infusion

p-value

Heart Rate (beats/min)

253 ± 22

207 ± 35

0.091

Left Atrium (mm)

6.2 ± 0.8

5.5 ± 0.7

0.037

LVEDD (mm)

11.6 ± 1.09

9.0 ± 1.51

0.003

LVESD (mm)

7.8 ± 0.91

5.4 ± 1.30

0.009

FS (%)

32.1 ± 3.4

41.1 ± 5.3

0.004

EF (%)

65.0 ± 4.7

76.6 ± 5.8

0.002

Stroke Volume (ml)

0.19 ± 0.06

0.36 + 0.11

0.011

Cardiac Output (ml/min)

44 ± 16

76 ± 14

0.027

SWTs (mm)

2.67± 0.48

3.33 ± 0.51

0.390

SWTd (mm)

1.6 ± 0.17

2.4 ± 0.39

0.274

Systolic time (ms)

133 ± 7

147 ± 8

0.003

Diastolic time (ms)

127 ± 16

141 ± 33

0.384

PEP (ms)

25.0 ± 2.3

22.4 ± 1.8

0.042

LVET (ms)

108 ± 6

125 ± 9

0.002

PEP/LVET

0.23 ± 0.02

0.18 ± 0.02

0.007

Systolic time/RR

0.51 ± 0.04

0.52 ± 0.06

0.735

  1. Values are mean ± SD. LVEDD Left ventricle end-diastolic diameter, LVEDV Left ventricle end-diastolic volume, LVESD Left ventricle end-systolic diameter, LVESD Left ventricle end-systolic volume, FS Fractional shortening, EF Ejection fraction, SV stroke volume, SWTs septal wall thickness at end-systole, SWTd septal wall thickness at end-diastole, PEP aortic pre-ejection period, LVET Left ventricular ejection time, RR inter-beat interval